Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P, Casazza G, Piva L, Luksch R, Perotti D, Pession A, Fagioli F, Dallorso S. Spreafico F, et al. Among authors: luksch r. Pediatr Blood Cancer. 2008 Jul;51(1):23-8. doi: 10.1002/pbc.21524. Pediatr Blood Cancer. 2008. PMID: 18293386 Clinical Trial.
A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients.
Cesaro S, Tintori V, Nesi F, Schiavello E, Calore E, Dallorso S, Migliavacca M, Capolsini I, Desantis R, Caselli D, Fagioli F, Luksch R, Panizzolo I, Tridello G, Prete A. Cesaro S, et al. Among authors: luksch r. Transfusion. 2013 Jul;53(7):1501-9. doi: 10.1111/j.1537-2995.2012.03911.x. Epub 2012 Oct 3. Transfusion. 2013. PMID: 23034006
Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.
Corrias MV, Parodi S, Tchirkov A, Lammens T, Vicha A, Pasqualini C, Träger C, Yáñez Y, Dallorso S, Varesio L, Luksch R, Laureys G, Valteau-Couanet D, Canete A, Pöetschger U, Ladenstein R, Burchill SA. Corrias MV, et al. Among authors: luksch r. Pediatr Blood Cancer. 2018 Jul;65(7):e27052. doi: 10.1002/pbc.27052. Epub 2018 Mar 30. Pediatr Blood Cancer. 2018. PMID: 29603574 Free article. Clinical Trial.
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Faraci M, Bertaina A, Luksch R, Calore E, Lanino E, Saglio F, Prete A, Menconi M, De Simone G, Tintori V, Cesaro S, Santarone S, Orofino MG, Locatelli F, Zecca M. Faraci M, et al. Among authors: luksch r. Biol Blood Marrow Transplant. 2019 Feb;25(2):313-320. doi: 10.1016/j.bbmt.2018.09.027. Epub 2018 Sep 26. Biol Blood Marrow Transplant. 2019. PMID: 30266674 Free article. Clinical Trial.
Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC).
Morland B, Kepak T, Dallorso S, Sevilla J, Murphy D, Luksch R, Yaniv I, Bader P, Rößler J, Bisogno G, Maecker-Kolhoff B, Lang P, Zwaan CM, Sumerauer D, Kriván G, Bernard J, Liu Q, Doyle E, Locatelli F. Morland B, et al. Among authors: luksch r. Bone Marrow Transplant. 2020 Sep;55(9):1744-1753. doi: 10.1038/s41409-020-0836-2. Epub 2020 Mar 3. Bone Marrow Transplant. 2020. PMID: 32127657 Free PMC article. Clinical Trial.
Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the Stem Cell Transplant and the Infectious Disease Working Groups of the AIEOP network.
Zama D, Masetti R, Baccelli F, Leardini D, Muratore E, Abram N, Vendemini F, Biffi A, Perruccio K, D'Amico MR, Faraci M, Tintori V, Spirito A, Lo Nigro L, Locatelli F, Luksch R, Saglio F, Santoro N, Soncini E, Zecca M, Ziino O, Prete A, Pagliara D, Cesaro S. Zama D, et al. Among authors: luksch r. Bone Marrow Transplant. 2022 Dec;57(12):1851-1853. doi: 10.1038/s41409-022-01793-5. Epub 2022 Oct 7. Bone Marrow Transplant. 2022. PMID: 36207623 No abstract available.
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Prete A, Lanino E, Saglio F, Biffi A, Calore E, Faraci M, Rondelli R, Favre C, Zecca M, Casazza G, Porta F, Luksch R, Cesaro S, Rabusin M, Parasole R, Mura RM, Lo Nigro L, Leardini D, Pagliara D, Locatelli F, Fagioli F; AIEOP-BMT Group. Prete A, et al. Among authors: luksch r. Transplant Cell Ther. 2024 May;30(5):530.e1-530.e8. doi: 10.1016/j.jtct.2024.03.002. Epub 2024 Mar 7. Transplant Cell Ther. 2024. PMID: 38460729 Free article. Clinical Trial.
199 results